Genome MedicineBioinformaticsPeer-reviewed journal article
Recommendations for Bioinformatics in Clinical Practice
Ksenia Lavrichenko, Emilie Sofie EngdaliD, Rasmus L. MarvigiD, Anders JemtiD, Jone Marius Vignes, Henrikki Almusa, Kristine Bilgrav SætheriD, Eiríkur BriemiD, Eva CaceresiD, Edda María Elvarsdóttir, Magnús Halldór GíslasoniD, Maria K. HaanpääiD, Viktor Henmyr, Ronja HotakaineniD, Eevi KaasineniD, Roan Kanninga, Sofia KhaniD, Mary Gertrude Lie-Nielsen, Majbritt Busk MadseniD, Niklas MähleriD, Khurram MaqbooliD, Ramprasad NeethirajiD, Karl Nyrén, Minna Paavola, Peter PruisscheriD, , Frederik Otzen BaggeriD
Abstract
Next Generation Sequencing (NGS) is increasingly used in clinical diagnostics, largely driven by the success and robustness of Whole Genome Sequencing (WGS). Whereas updated guidelines exist for how to interpret and report on variants that are identified from NGS using bioinformatics pipelines, there is a need for standardised bioinformatics practices for diagnostics to ensure clinical consensus, accuracy, reproducibility and comparability of the results. This article presents consensus recommendations developed by 13 clinical bioinformatics units taking part in the Nordic Alliance for Clinical Genomics (NACG), by expert bioinformaticians working in clinical production. The recommendations are based on clinical practice and focus on analysis types, test and validation, standardisation and accreditation, as well as core competencies and technical management required for clinical bioinformatics operations. Key recommendations include adopting the hg38 genome build as the reference and a standard set of recommended analyses, including the use of multiple tools for structural variant (SV) calling and in-house data sets for filtering recurrent calls. Clinical bioinformatics production should operate under the ISO 15189 standard, utilising off-grid clinical-grade high-performance computing systems, standardised file formats, and strict code version control. Containerized software containers or environment management systems are needed to ensure reproducibility. Pipelines should be rigorously documented and tested for accuracy and reproducibility, minimally covering unit, integration, and end-to-end testing. Standard truth sets such as GIAB and SEQC2 for germline and somatic variant calling, respectively, should be supplemented by recall testing of previously validated clinical cases. Data integrity must be verified using file hashing, and sample identity should be checked via sample fingerprinting and genetically inferred identification markers such as sex and relatedness. Finally, clinical bioinformatics teams should encompass diverse skills, including software development, data management, quality assurance, and domain expertise in human genetics. These recommendations provide a consensus framework for standardising bioinformatics practices across clinical WGS applications and can serve as a practical guide to facilities that are new to large-scale sequencing-based diagnostics, or as a reference for those who already run high-volume clinical production using NGS.
- organism: human
- assay: whole-genome sequencing
- research focus: benchmarking
- research focus: variant calling
- research focus: database / resource
- approach: statistical model
- approach: benchmark study
- Citations
- 21
- FWCI
- 3.18
- Field percentile
- top 6%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- CBIcall: a configuration-driven framework for variant calling in large sequencing cohorts
Manuel Rueda, Dietmar Fernández‐Orth, Ivo Glynne Gut·Bioinformatics AdvancesPeer-reviewed·Jan 1, 2026
- Software-assisted manual review of clinical NGS data:an alternative to routine Sanger sequencing confirmationwith equivalent results in >15,000 hereditary cancer screens
Dale Muzzey, Shera F. Kash, … Kevin R. Haas·bioRxiv·Sep 23, 2018
- Evaluation of false positive and false negative errors in targeted next generation sequencing
Youngbeen Moon, Young-Ho Kim, … Kyeong‐Man Hong·Genome biologyPeer-reviewed·Dec 1, 2025
- A Rigorous Interlaboratory Examination of the Need to Confirm NGS-Detected Variants by an Orthogonal Method in Clinical Genetic Testing
Stephen E. Lincoln, Rebecca Truty, … Matthew S. Lebo·Journal of Molecular DiagnosticsPeer-reviewed·Jan 2, 2019
- Achieving reproducibility and accuracy in cancer mutation detection with whole-genome and whole-exome sequencing
Wenming Xiao, Luyao Ren, … Leming M. Shi·Nature BiotechnologyPeer-reviewed·Sep 1, 2021
- Enabling Precision Medicine via standard communication of NGS provenance, analysis, and results
G. Alterovitz, D. A. Dean, … R. Mazumder·bioRxiv·Nov 5, 2018